K2M

K2M was a U.S.-based medical device company focused on designing, developing, and commercializing complex spine and minimally invasive spine technologies for surgeons. Its portfolio included spinal implants, instruments, biologic solutions, and enabling technologies used to treat challenging spinal pathologies such as deformity, scoliosis, trauma, tumor, and degenerative conditions. The company was known for products in posterior fixation, interbody fusion, cervical systems, minimally invasive surgery, and 3D-printed spinal solutions. K2M was founded in 2004, went public on Nasdaq under the symbol KTWO, and was acquired by Stryker in November 2018. Following the acquisition, K2M's technologies and product lines were integrated into Stryker's spine business.